Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-10 of 10 for your search:
Cancer Type/Condition:
Wilms tumor
Stage/Subtype:
stage IV Wilms tumor
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer
Phase:
Phase IV
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and under
Sponsor:
NICHD
Protocol IDs:
PPRU 10762
, NCT00491946
2.
Phase III Randomized Study of Glutamic Acid in Reducing Vincristine-Related Peripheral Neurotoxicity in Young Patients Undergoing Vincristine-Containing Treatment for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Phase:
Phase III
Type:
Supportive care, Treatment
Status:
Active
Age:
3 to 20
Sponsor:
NCI
Protocol IDs:
HLMCC-0402
, NCT00369564, ACCL 0731
3.
Phase III Study of Combination Chemotherapy With or Without Radiotherapy in Patients With Newly Diagnosed Stage III or IV Favorable Histology Wilms' Tumor
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 30
Sponsor:
NCI
Protocol IDs:
COG-AREN0533
, AREN0533, NCT00379340
4.
Phase III Study of Combination Chemotherapy and Surgery in Young Patients With Bilateral, Multicentric, or Bilaterally Predisposed Unilateral Wilms Tumor
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 30 at initial diagnosis
Sponsor:
NCI
Protocol IDs:
COG-AREN0534
, AREN0534, NCT00945009
5.
Phase II Study of Combination Chemotherapy, Radiotherapy, and/or Surgery in Patients With High-Risk Renal Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
30 and under
Sponsor:
NCI
Protocol IDs:
COG-AREN0321
, AREN0321, NCT00335556
6.
Phase I Study of Lexatumumab With or Without Recombinant Interferon Gamma in Pediatric Patients With Relapsed or Refractory Solid Tumors or Lymphoma
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
1 to 30
Sponsor:
NCI
Protocol IDs:
NCI-07-C-0040
, NCI-P6981, NCT00428272
7.
Phase I Study of Trabectedin in Pediatric Patients With Relapsed or Refractory Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
4 to 16
Sponsor:
NCI
Protocol IDs:
NCI-07-C-0054
, NCT00437047
8.
Phase I Study of Ipilimumab (Anti-CTLA-4) in Children, Adolescents, and Young Patients With Advanced or Refractory Solid Tumors
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
2 to 21
Sponsor:
NCI
Protocol IDs:
NCI-08-C-0007
, 08-C-0007, NCI-P6068, 7458, NCT00556881
9.
Phase I Study of Total Marrow Irradiation With Helical Tomotherapy Image-Guided Intensity-Modulated Radiotherapy Followed by Alkylator-Intense Conditioning Comprising Busulfan, Melphalan, and Thiotepa and Autologous CD34+ Hematopoietic Progenitor Cell Transplantation in Patients With High-Risk or Relapsed Solid Tumors
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Diagnostic, Treatment
Status:
Active
Age:
70 and under
Sponsor:
NCI
Protocol IDs:
UMN-2005LS023
, UMN-2005LS023, UMN-MT2004-30, NCT00623077
10.
Respiratory Tumor and Normal Tissue Motion
Phase:
No phase specified
Type:
Natural history/Epidemiology, Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
2003-0962
, NCT00415675
Select All on Page
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
